<\/p>\n
Kenacort Injection<\/strong> is a sterile depot suspension from Abbott Healthcare containing triamcinolone acetonide<\/strong> la 10 mg\/mL and 40 mg\/mL vials<\/strong>, supplied for intramuscular (IM) or intra-articular (IA) injection<\/strong>. Triamcinolone acetonide is highly insoluble — once injected it forms a microcrystalline depot that releases active drug slowly over 2–6 weeks<\/strong>, giving prolonged anti-inflammatory effect from a single injection. Common uses: intra-articular injection<\/strong> for knee, shoulder and small-joint inflammation in osteoarthritis or rheumatoid arthritis; intramuscular depot<\/strong> for severe seasonal allergic rhinitis, dermatologic flares, asthma exacerbations not requiring hospitalisation; intralesional injection<\/strong> for hypertrophic scars, keloids, alopecia areata, localised psoriasis. Joint-injection limits<\/strong>: no more than 3–4 injections per joint per year<\/strong>, no more than one injection every 3 months<\/strong> per joint — more frequent use accelerates cartilage damage. Local side effects include skin atrophy and depigmentation around the injection site, fat atrophy at IM sites, post-injection joint flare, and (rarely) septic arthritis. Systemic effects mimic oral steroids in proportion to the cumulative dose absorbed.<\/p>\n<\/div>\n <\/p>\n \ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n Kenacort Injection is a depot suspension for intramuscular and intra-articular injection manufactured by Abbott Healthcare containing triamcinolone acetonide<\/strong> \u2014 un corticosteroid sintetic din clasa glucocorticoidelor. Glucocorticoidele sunt cele mai puternice medicamente antiinflamatoare \u0219i imunosupresoare cu spectru larg disponibile, cu efecte \u00een aproape fiecare \u021besut \u0219i sistem de organe.<\/p>\n Kenacort Injection is the original Indian-market injectable triamcinolone acetonide depot from Abbott Healthcare. The 10 mg\/mL strength<\/strong> is used for small-joint intra-articular injection and intralesional dermatology (alopecia, scars). The 40 mg\/mL strength<\/strong> is used for intramuscular depot, large-joint intra-articular (knee, shoulder) and high-dose intralesional treatment of keloid scars.<\/p>\n Triamcinolone 4 mg is approximately equivalent to prednisolone 5 mg (potency ratio ~5). The physiological daily cortisol output of a healthy adult is approximately 5–7.5 mg of prednisolone-equivalent — any dose above that is “supraphysiological” and begins to suppress the hypothalamic-pituitary-adrenal (HPA) axis.<\/p>\n Why a depot suspension?<\/strong> Triamcinolone acetonide is far less water-soluble than the sodium-phosphate or sodium-succinate esters used for IV steroids. Once injected, it forms microscopic crystals that dissolve over weeks, providing sustained low-dose glucocorticoid release without the daily-dosing burden of oral therapy. This is ideal for joint inflammation (where an injection inside the joint capsule keeps the drug locally concentrated), severe seasonal allergy (one IM injection covers most of the pollen season), and dermatology (localised intralesional injection of keloids, alopecia patches, hypertrophic scars).<\/p>\n Triamcinolone enters cells, binds the receptorul intracelular de glucocorticoid<\/strong>, iar complexul receptor-medicament se transloc\u0103 \u00een nucleu, unde modific\u0103 transcrip\u021bia a sute de gene. Rezultatul final este o atenuare larg\u0103 a cascadei inflamatorii:<\/p>\n Clinical onset (depot IM\/IA): noticeable improvement within 24\u201348 de ore<\/strong> for joint inflammation; peak effect at 7–14 days. Total duration of useful effect: 2–6 weeks<\/strong> (joint), 3\u20136 s\u0103pt\u0103m\u00e2ni<\/strong> (IM depot for allergic rhinitis), 2–3 months<\/strong> (intralesional in keloid scars).<\/p>\n Kenacort Injection is used wherever sustained local or systemic glucocorticoid effect is wanted from a single injection.<\/p>\n Kenacort Injection is prime\u0219te,<\/strong> appropriate for: routine first-line management of osteoarthritis (lifestyle, weight, physiotherapy and NSAIDs first), septic arthritis (steroid is contraindicated until infection cleared), spinal injection (has been associated with rare but devastating cord infarction — best avoided in favour of soluble preparations), or any joint that has been injected within the past 3 months.<\/p>\n Kenacort Injection is supplied at 10 mg\/mL and 40 mg\/mL vials<\/strong>. Dose depends entirely on the indication and the route — this is a specialist or trained-clinician procedure<\/strong>, not for self-administration.<\/p>\nDe ce s\u0103 comanzi de la MedsBase<\/h3>\n
What Is Kenacort Injection?<\/h2>\n
How Does Kenacort Injection Work?<\/h2>\n
\n
Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n
Intra-articular (IA) injection — into a joint<\/h3>\n
\n
Intramuscular (IM) depot — gluteal injection<\/h3>\n
\n
Intralesional injection — into the lesion<\/h3>\n
\n
Kenacort Injection Dosage and How to Use<\/h2>\n
Typical adult doses by route and indication<\/h3>\n